Science ❯ Medical Research

Infectious Diseases

Vaccine Development Viral Infections HIV Research Ebola Virus Epidemiology Vaccine Research Tuberculosis COVID-19 Flu Virus Dengue Virus Avian Influenza Tuberculosis Studies Pediatrics Vector-borne Diseases Laboratory Testing Mpox Rabies Virus COVID-19 Research Influenza Antibody Testing Antimicrobial Resistance Hepatitis B Virus Hepatitis B HIV Chikungunya Treatment Development Human Papillomavirus Measles Respiratory Diseases Vaccine Technology Covid-19 Malaria Bacteria Respiratory Infections Oncology Influenza Virus Antibiotic Resistance Viral Hepatitis Long COVID Post-Viral Syndromes Ebola Pasteur Institute of Iran Post-Infectious Conditions Vaccination HIV/AIDS Measles Complications Flu Vaccines

Moderna Begins Phase III Trial of mRNA Bird Flu Vaccine in UK and US

The study tests a fast‑to‑update mRNA shot to boost pandemic readiness against an evolving H5N1 threat.

Flu Toll Rises in New England: 6 Pediatric Deaths in Mass., 35 Total in N.H.

GSK and Ionis Report Phase 3 Success for Hepatitis B Drug, Plan Q1 Filings

CEPI Puts Up to $54.3 Million Behind Moderna’s H5 mRNA Bird Flu Vaccine for Phase 3

Jeanne Marrazzo Sues Trump Administration Over Firing, Alleging Retaliation for NIH Cuts Warning

Co-Diagnostics, Arabian Eagle Form CoMira JV to Localize PCR Platform Across Saudi Arabia and MENA

NIH Whistle-Blowers Allege Vaccine Skepticism and Politicized Grantmaking at the Top

HHS Axes $500 Million in BARDA mRNA Vaccine Projects, Drawing Intensifying Warnings